表纸
市场调查报告书

缓释性注射剂

Sustained Release Injectables to 2026

出版商 Greystone Research Associates 商品编码 672887
出版日期 内容资讯 英文
商品交期: 最快1-2个工作天内
价格
Back to Top
缓释性注射剂 Sustained Release Injectables to 2026
出版日期: 2019年08月06日内容资讯: 英文
简介

本报告提供缓释性注射剂调查分析,上市产品,制剂技术,需求促进因素,市场潜在性与课题,治疗药市场区隔,市场影响要素等系统性资讯。

摘要整理

注射剂市场趋势

  • 自我给药趋势
  • 注射剂的制剂技术
  • 注射用设备设计的创新
  • 治疗的需求促进因素
  • 市场要素
  • 竞争情形
  • 危险因素

缓释性制剂技术

  • 生物分解性高分子
  • SR制剂技术品牌化
  • 物理的流程的管理方法

缓释性注射剂 - 开发要素

  • 制剂要素
  • 稳定性
  • 冷冻干燥
  • 包装
  • 给药要素

缓释性产品情势

  • 生物鹼
  • 麻醉剂
  • 抗癌药物
  • GnRH受体激动剂
  • 类鸦片物质拮抗剂
  • 合成肽
  • 细胞激素
  • 荷尔蒙
  • 抗精神病药
  • 其他

开发阶段的SR注射剂

SR注射剂 - 治疗药市场部门分析与预测

  • 依赖
  • 内分泌学
  • 血糖管理
  • 感染疾病
  • 荷尔蒙缺乏症
  • 代谢疾病
  • 神经学
  • 肿瘤学
  • 白血病
  • 淋巴瘤
  • 前列腺
  • 疼痛管理
  • 生殖健康

企业简介

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: SJB982

Currently approved sustained release injectables rely on a spectrum of branded formulation technologies to modulate the drug's release profile post-injection. Typically off-patent or generic drugs, they include drug therapies for almost a dozen major therapeutic segments, including neurological conditions, metabolic diseases, oncology, pain management and reproductive health. As the incidence and prevalence of chronic illnesses increases with the aging population, the attraction and interest in sustained release injectables will increase.

Sustained Release Injectables - What You Will Learn

  • What are the marketed sustained release injectable drug products, what sustained release formulation technologies are used, and who markets them?
  • What are the major factors driving sustained release injectable drug demand?
  • What sustained release injectable drug candidates are in late-stage clinical development and what is their potential impact?
  • How important are drug developer-formulation technologist relationships in the sustained release market segment, and what are the key alliances in the industry?
  • What are the essential formulation factors, delivery device selection issues, related technology factors and market development issues for sustained release injectable drug products?
  • In what therapeutic market segments do sustained release injectables compete? What is their market share today? What will it be in 2022? What is their expected growth rate?
  • What are the significant economic, technology, and regulatory factors affecting the market for sustained release injectables?

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

  • The Trend toward Self-Administration
  • Injectable Drug Formulation Technology
  • Innovation in Injectable Device Designs
  • Therapeutic Demand Drivers
  • Market Factors
  • Competitive Landscape
  • Risk Factors

Sustained Release Formulation Technologies

  • Biodegradable Polymers
  • Branded SR Formulation Technologies
  • Physical Process Control Methods

Sustained Release Injectables - Development Factors

  • Formulation Factors
  • Stability
  • Lyophilization
  • Packaging
  • Administration Factors

The Sustained Release Product Landscape

  • Alkaloids
  • Anesthetics
  • Antineoplastics
  • GnRH Agonists
  • Opioid Antagonists
  • Synthetic Peptides
  • Cytokines
  • Hormones
  • Antipsychotics
  • Other Drug Classes

Development-stage SR Injectables

SR Injectables - Therapeutic Market Sector Analysis & Forecasts

  • Addiction
  • Endocrinology
  • Glycemic Control
  • Infectious Disease
  • Hormone Deficiency
  • Metabolic Diseases
  • Neurology
  • Oncology
  • Leukemia
  • Lymphoma
  • Prostate
  • Pain Management
  • Reproductive Health

Company Profiles

Back to Top